MATHEMATICAL DETECTIVES DETAIL A DEADLY DISEASE

Five years ago, Mac Hyman began to worry about AIDS. “I was convinced that the problem was very much larger than the people around me were reacting to,” recalls Hyman, a mathematical modeler at Los Alamos (N.Mex.) National Laboratory. “There just wasn’t any other problem that was crying out like this.” Driven by this conviction, Hyman convinced fellow mathematicians, social scientists, computer specialists, and medical experts to help him build a theoretical mod

Written byElizabeth Pennisi
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

Five years ago, Mac Hyman began to worry about AIDS. “I was convinced that the problem was very much larger than the people around me were reacting to,” recalls Hyman, a mathematical modeler at Los Alamos (N.Mex.) National Laboratory. “There just wasn’t any other problem that was crying out like this.”

Driven by this conviction, Hyman convinced fellow mathematicians, social scientists, computer specialists, and medical experts to help him build a theoretical model of the disease. Their efforts have enlarged the work of a cadre or biostatisticians tracking the course or the disease and evaluating ways to slow the epidemic. Although they take different approaches—statisticians work within the confines of existing data, while mathematicians juggle the more theoretical elements of the epidemic—the numbers may save lives by pinpointing flaws in our understanding of the disease. Models also identify what is not yet known about AIDS.

“Trying to model how the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies